It results from subcutaneous needle insertion and temporary nerve ending irritation, and is generally benign when brief and self-limiting
Taste disturbance is not listed among the common adverse reactions in the Zepbound prescribing information, which means it either did not occur frequently enough in clinical trials to warrant inclusion or was not systematically captured as a distinct adverse event
With the exception of His1, the largest difference in the interaction of GLP-1 and exendin-4 occurred within the mid-region of the peptides where their sequences differ substantially (E 16 EAVRL 21 for exendin-4 vs G 22 QAAKE 27 for GLP-1)
This is most relevant for medicines where timing or a narrow therapeutic range matters
Prioritizing protein content, fat, calorie, and sugar reduction while boosting the nutritional value of products will be essential to support GLP-1 usage for weight reduction
Tirzepatide price comparison